Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126261181 | 12626118 | 1 | I | 20160727 | 20160805 | 20160805 | EXP | GR-AMGEN-GRCSP2016099544 | AMGEN | 51.00 | YR | A | F | Y | 0.00000 | 20160805 | MD | GR | GR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126261181 | 12626118 | 1 | PS | XGEVA | DENOSUMAB | 1 | Unknown | UNK | U | 125320 | SOLUTION FOR INJECTION | ||||||||
| 126261181 | 12626118 | 2 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | UNK | 0 | ||||||||||
| 126261181 | 12626118 | 3 | SS | DOCETAXEL. | DOCETAXEL | 1 | Unknown | UNK | 0 | ||||||||||
| 126261181 | 12626118 | 4 | SS | EXEMESTANE. | EXEMESTANE | 1 | Unknown | UNK | 0 | ||||||||||
| 126261181 | 12626118 | 5 | SS | ERIBULIN | ERIBULIN | 1 | Unknown | UNK | 0 | ||||||||||
| 126261181 | 12626118 | 6 | SS | GEMCITABINE HYDROCHLORIDE. | GEMCITABINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 126261181 | 12626118 | 7 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126261181 | 12626118 | 8 | SS | EVEROLIMUS | EVEROLIMUS | 1 | Unknown | UNK | 0 | ||||||||||
| 126261181 | 12626118 | 9 | SS | LIPOSOMAL DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126261181 | 12626118 | 1 | Breast cancer metastatic |
| 126261181 | 12626118 | 2 | Breast cancer metastatic |
| 126261181 | 12626118 | 4 | Breast cancer metastatic |
| 126261181 | 12626118 | 5 | Breast cancer metastatic |
| 126261181 | 12626118 | 6 | Breast cancer metastatic |
| 126261181 | 12626118 | 7 | Breast cancer metastatic |
| 126261181 | 12626118 | 8 | Breast cancer metastatic |
| 126261181 | 12626118 | 9 | Breast cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126261181 | 12626118 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126261181 | 12626118 | Disease progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126261181 | 12626118 | 1 | 201102 | 0 | ||
| 126261181 | 12626118 | 2 | 201102 | 201412 | 0 | |
| 126261181 | 12626118 | 3 | 201509 | 201511 | 0 | |
| 126261181 | 12626118 | 4 | 201502 | 201509 | 0 | |
| 126261181 | 12626118 | 5 | 201604 | 201606 | 0 | |
| 126261181 | 12626118 | 6 | 201509 | 201511 | 0 | |
| 126261181 | 12626118 | 7 | 201102 | 201412 | 0 | |
| 126261181 | 12626118 | 8 | 201502 | 201509 | 0 | |
| 126261181 | 12626118 | 9 | 201512 | 201603 | 0 |